Cargando…

The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States

Background Although the sudden coronavirus disease 2019 (COVID-19) pandemic would have significantly influenced financial relationships between the healthcare industry and gastroenterologists and hepatologists, little is known about the trend in financial relations in the United States. This study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Murayama, Anju, Kamamoto, Sae, Saito, Hiroaki, Tanimoto, Tetsuya, Ozaki, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849032/
https://www.ncbi.nlm.nih.gov/pubmed/36686074
http://dx.doi.org/10.7759/cureus.32711
_version_ 1784871851132977152
author Murayama, Anju
Kamamoto, Sae
Saito, Hiroaki
Tanimoto, Tetsuya
Ozaki, Akihiko
author_facet Murayama, Anju
Kamamoto, Sae
Saito, Hiroaki
Tanimoto, Tetsuya
Ozaki, Akihiko
author_sort Murayama, Anju
collection PubMed
description Background Although the sudden coronavirus disease 2019 (COVID-19) pandemic would have significantly influenced financial relationships between the healthcare industry and gastroenterologists and hepatologists, little is known about the trend in financial relations in the United States. This study, thus, aimed to examine the trends in industry payments made to gastroenterologists and hepatologists during the COVID-19 pandemic. Materials and methods Using the Open Payments Database between 2013 and 2021, we evaluated trends in financial relationships between the healthcare industry and gastroenterologists and hepatologists in the United States. Trends in general payments during the COVID-19 pandemic were evaluated by interrupted time series analysis with monthly and yearly payments at the physician level. Results A total of 16,808 or 89.4% of all active gastroenterologists received general payments totaling $393,823,094 from the pharmaceutical and medical device companies between 2013 and 2021. The payment per gastroenterologist and the number of gastroenterologists receiving payments decreased by 70.9% (95% CI: -73.4% - -68.1%, p<0.001) and by 51.5% (95%CI: -52.2% - -50.7%, p<0.001) due to the onset of the COVID-19 pandemic, respectively. However, both payments and the number of physicians with payments have recovered monthly since the COVID-19 pandemic, with relative monthly change rates of 4.1% (95% CI: 3.5% ‒ 4.7%, p<0.001) and 3.2% (95%CI: 3.1% ‒ 3.2%, p<0.001). Additionally, the general payments per gastroenterologist significantly decreased by 2.5% (95%CI: -3.9% - -1.1%, p<0.001) each year before the COVID-19 pandemic, while there was a very small change in the number of gastroenterologists with payments. Conclusions The industry payments to gastroenterologists and hepatologists significantly decreased due to the COVID-19 pandemic, but the payments have recovered right after the pandemic in the United States.
format Online
Article
Text
id pubmed-9849032
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-98490322023-01-19 The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States Murayama, Anju Kamamoto, Sae Saito, Hiroaki Tanimoto, Tetsuya Ozaki, Akihiko Cureus Gastroenterology Background Although the sudden coronavirus disease 2019 (COVID-19) pandemic would have significantly influenced financial relationships between the healthcare industry and gastroenterologists and hepatologists, little is known about the trend in financial relations in the United States. This study, thus, aimed to examine the trends in industry payments made to gastroenterologists and hepatologists during the COVID-19 pandemic. Materials and methods Using the Open Payments Database between 2013 and 2021, we evaluated trends in financial relationships between the healthcare industry and gastroenterologists and hepatologists in the United States. Trends in general payments during the COVID-19 pandemic were evaluated by interrupted time series analysis with monthly and yearly payments at the physician level. Results A total of 16,808 or 89.4% of all active gastroenterologists received general payments totaling $393,823,094 from the pharmaceutical and medical device companies between 2013 and 2021. The payment per gastroenterologist and the number of gastroenterologists receiving payments decreased by 70.9% (95% CI: -73.4% - -68.1%, p<0.001) and by 51.5% (95%CI: -52.2% - -50.7%, p<0.001) due to the onset of the COVID-19 pandemic, respectively. However, both payments and the number of physicians with payments have recovered monthly since the COVID-19 pandemic, with relative monthly change rates of 4.1% (95% CI: 3.5% ‒ 4.7%, p<0.001) and 3.2% (95%CI: 3.1% ‒ 3.2%, p<0.001). Additionally, the general payments per gastroenterologist significantly decreased by 2.5% (95%CI: -3.9% - -1.1%, p<0.001) each year before the COVID-19 pandemic, while there was a very small change in the number of gastroenterologists with payments. Conclusions The industry payments to gastroenterologists and hepatologists significantly decreased due to the COVID-19 pandemic, but the payments have recovered right after the pandemic in the United States. Cureus 2022-12-19 /pmc/articles/PMC9849032/ /pubmed/36686074 http://dx.doi.org/10.7759/cureus.32711 Text en Copyright © 2022, Murayama et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Gastroenterology
Murayama, Anju
Kamamoto, Sae
Saito, Hiroaki
Tanimoto, Tetsuya
Ozaki, Akihiko
The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States
title The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States
title_full The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States
title_fullStr The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States
title_full_unstemmed The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States
title_short The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States
title_sort trend in industry payments during the covid-19 pandemic among gastroenterologists and hepatologists in the united states
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849032/
https://www.ncbi.nlm.nih.gov/pubmed/36686074
http://dx.doi.org/10.7759/cureus.32711
work_keys_str_mv AT murayamaanju thetrendinindustrypaymentsduringthecovid19pandemicamonggastroenterologistsandhepatologistsintheunitedstates
AT kamamotosae thetrendinindustrypaymentsduringthecovid19pandemicamonggastroenterologistsandhepatologistsintheunitedstates
AT saitohiroaki thetrendinindustrypaymentsduringthecovid19pandemicamonggastroenterologistsandhepatologistsintheunitedstates
AT tanimototetsuya thetrendinindustrypaymentsduringthecovid19pandemicamonggastroenterologistsandhepatologistsintheunitedstates
AT ozakiakihiko thetrendinindustrypaymentsduringthecovid19pandemicamonggastroenterologistsandhepatologistsintheunitedstates
AT murayamaanju trendinindustrypaymentsduringthecovid19pandemicamonggastroenterologistsandhepatologistsintheunitedstates
AT kamamotosae trendinindustrypaymentsduringthecovid19pandemicamonggastroenterologistsandhepatologistsintheunitedstates
AT saitohiroaki trendinindustrypaymentsduringthecovid19pandemicamonggastroenterologistsandhepatologistsintheunitedstates
AT tanimototetsuya trendinindustrypaymentsduringthecovid19pandemicamonggastroenterologistsandhepatologistsintheunitedstates
AT ozakiakihiko trendinindustrypaymentsduringthecovid19pandemicamonggastroenterologistsandhepatologistsintheunitedstates